News

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...
Chronic hepatitis B is a viral infection that can currently only be treated with interferon-α and nucleosidic inhibitors of viral polymerase — 3TC and adefovir — but these treatments are limited by ...
UD researchers, Jodi Hadden and Juan Perilla, have used computer simulations to learn more about the capsid, or protein shell, that encloses the genetic blueprint of the hepatitis B virus.
At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...
While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
Thomas Jeffries does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
Monotherapy with the Capsid Assembly Modulator ALG-000184 Results in Rapid Viral Load Reduction and High Viral Suppression Rates in Untreated HBeAg-Negative Subjects with Chronic Hepatitis B Virus ...